Volume 57, Issue 52 pp. 17043-17047
Communication

Selective Degradation of Polo-like Kinase 1 by a Hydrophobically Tagged Inhibitor of the Polo-Box Domain

Stefan Rubner

Stefan Rubner

Leipzig University, Institute of Organic Chemistry, Johannisallee 29, 04103 Leipzig, Germany

These authors contributed equally to this work.

Search for more papers by this author
Dr. Andrej Scharow

Dr. Andrej Scharow

Leipzig University, Institute of Organic Chemistry, Johannisallee 29, 04103 Leipzig, Germany

These authors contributed equally to this work.

Search for more papers by this author
Sabine Schubert

Sabine Schubert

Leipzig University, Institute of Organic Chemistry, Johannisallee 29, 04103 Leipzig, Germany

Search for more papers by this author
Prof. Dr. Thorsten Berg

Corresponding Author

Prof. Dr. Thorsten Berg

Leipzig University, Institute of Organic Chemistry, Johannisallee 29, 04103 Leipzig, Germany

Search for more papers by this author
First published: 23 October 2018
Citations: 30

Graphical Abstract

Misleading signals: The first application of hydrophobic tagging to an existing inhibitor of protein-protein interactions is presented. Poloxin-2HT targets the Plk1 polo-box domain, and induces Plk1 degradation, characteristic mitotic phenotypes, and apoptosis in human tumor cells.

Abstract

Hydrophobic tagging (HT) of bioactive compounds can induce target degradation via the proteasomal pathway. The first application of hydrophobic tagging to an existing inhibitor of protein–protein interactions is now presented. We developed Poloxin-2HT by fusing an adamantyl tag to Poloxin-2, an inhibitor of the polo-box domain of the protein kinase Plk1, which is a target for tumor therapy. Poloxin-2HT selectively reduced the protein levels of Plk1 in HeLa cells and had a significantly stronger effect on cell viability and the induction of apoptosis than the untagged PBD inhibitor Poloxin-2. The change in cellular phenotype associated with the addition of the hydrophobic tag to Poloxin-2 demonstrated that Poloxin-2HT targets Plk1 in living cells. Our data validate hydrophobic tagging of selective inhibitors of protein–protein interactions as a novel strategy to target and destroy disease-relevant proteins.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.